-
Sign up for our new free newsletters for industry news, insight, and analysis: https://mailchi.mp/xconomy.com/subscribe-twitter-profile …
#Xconomists#XconXpertise#XconBioRoundup#XcelerateLS#XconSD#XconSF#XconNY#XconBOS#XconSEA#XconPHIpic.twitter.com/BW5Oav6cRA
-
Brain and neurological disorders are among the toughest conditions to diagnose and treat, but new approaches and technologies are on the horizon that could change how researchers and clinicians approach them. https://xconomy.com/xpertise/whats-next-neuroscience-therapies/ …
#xconxpertise pic.twitter.com/GUHGxaDnmR
-
New on
#XconXpertise:@Polaryx777 President & CEO Hahn-Jun Lee discusses the company's work accelerating availability of treatment options for underserved neurodegenerative disorder patients, and the scientific rationale behind their products. https://xconomy.com/xpertise/polaryx-therapeutics-lysosome-biogenesis-neurodegenerative-disorders/ …@EBDgroup -
New to
#XconXpertise: Nimble Therapeutics' CEO speaks about accelerating the development and discovery of peptide-based therapeutics, and making this tech available to other pharma companies. https://xconomy.com/xpertise/nimble-therapeutics-greatly-accelerates-development-of-peptide-based-therapeutics/ …@EBDgroup -
New to
#XconXpertise:@PharmabcineI CEO@wincancer speaks about the clinical stage immune-oncology company’s specializing in R&D of antibody treatments through its new-generation double target antibody production tech. https://xconomy.com/xpertise/pharmabcine-immune-oncology-cancer-treatments/ …@EBDgroup -
New to
#XconXpertise:@Rgenix co-founders speak about their clinical-stage cancer therapeutics work that uses genetic data and patient samples to validate the role of their novel targets. https://xconomy.com/xpertise/rgenix-cancer-therapeutics-company-rna-identify-novel-targets/ …@EBDgroup -
Watch Jeff Daelman of
@RousselotGlobal speak at BIO-Europe about X-Pure, an innovative range of purified gelatins and collagens designed explicitly for (bio)medical applications and backed by scientific data and ongoing research. https://xconomy.com/xpertise/rousselot-biomedicals-x-pure-changing-game-purified-gelatins/ …#XconXpertise@EBDgroup -
See Marco Cerato of
@Mundipharma speak at BIO-Europe about their success from “moving medicine forward” through development and commercialization of products with direct input from patients, physicians, payers, and other healthcare providers. https://xconomy.com/xpertise/mundipharmas-success-like-minded-partnerships/ …#XconXpertise -
See Louis Boon of Bioceros, part of Poland’s Polpharma Biologics Group, discuss its one-stop-shop CDMO at BIO-Europe. It offers novel technologies on their own platform, generating high-yield GMP-ready protein producing cell lines. https://xconomy.com/xpertise/bioceros-monoclonal-antibodies-polpharma-group/ …
@EBDgroup#XconXpertise -
See
@fideltaltd’s Adrijana Vinter speak at BIO-Europe about integrated drug discovery services, from target validation to preclinical development. Fidelta is more selective since it is smaller and focuses on infection/inflammation. https://xconomy.com/xpertise/fidelta-drug-discovery-infection-inflammation/ …@EBDgroup#XconXpertise -
New whitepaper now available on
#XconXpertise - What to Include in Your Life Sciences Company Fundraising Pitch Deck: https://xconomy.com/xpertise/what-to-include-in-your-life-sciences-company-fundraising-pitch-deck/ … - sponsored by@brexHQpic.twitter.com/pEPYkzvqh3
-
New whitepaper now on
#XconXpertise - Digitizing 10 Life Sciences Paper Processes: https://xconomy.com/xpertise/digitizing-10-life-sciences-paper-processes/ … - sponsored by@DocuSignpic.twitter.com/pDNvKD0pg6
-
New whitepaper now on
#XconXpertise - Potency Assay Development for Cell and Gene Therapy Products: https://xconomy.com/xpertise/potency-assay-development-cell-gene-therapy-products/ … - sponsored by@Absorb_Thispic.twitter.com/DgcgDtWcat
-
New to
#XconXpertise video: Learn about @Barc_Lab's lab space and network of scientific experts who work with their clients from early development through Phase III trials. https://xconomy.com/xpertise/barc-lab-expanding-globally-bring-personalized-approach-to-more-clients/ …#sponsoredpic.twitter.com/SybPwzKqif
-
New video up on
#XconXpertise: Tools4Patient aims to reduce effect of placebo response in clinical trials with predictive algorithms https://xconomy.com/xpertise/tools4patient-aims-to-reduce-effect-of-placebo-response-in-clinical-trials/ …#sponsoredpic.twitter.com/keT83HgGJP
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.